Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

56.76 +0.12 (+0.22%)
Streaming Delayed Price Updated: 12:20 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 448,046
Open 56.66
Bid (Size) 56.68 (4)
Ask (Size) 56.83 (2)
Prev. Close 56.63
Today's Range 55.37 - 57.98
52wk Range 37.55 - 91.10
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon. 
Via The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
These biotech stocks are poised to generate significant returns to investors due to their high growth potential. 
Via InvestorPlace

Performance

YTD
-14.09%
-14.09%
1 Month
+3.49%
+3.49%
3 Month
-19.11%
-19.11%
6 Month
-12.63%
-12.63%
1 Year
+1.68%
+1.68%

More News

Read More
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Via InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
Via InvestorPlace
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
Via InvestorPlace
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Via The Motley Fool
Is CRISPR Therapeutics a Millionaire Maker?
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Via The Motley Fool
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
Via The Motley Fool
7 Stocks You Haven’t Heard of (That EVERYONE Should Own)
Via InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
Via InvestorPlace
Is CRISPR Therapeutics Stock a Buy?
Via The Motley Fool
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
Via InvestorPlace
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition
Via InvestorPlace
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Via The Motley Fool
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
Via InvestorPlace
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024
Via InvestorPlace
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Via The Motley Fool
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Via The Motley Fool
The 3 Best Cathie Wood Stocks to Buy in May 2024
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
Via InvestorPlace
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Via InvestorPlace
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.